Biosensors & POCT– category –
-
Advanced Remote Health Monitoring: 24/7 Biosensor Tracking for Home Patients and Elderly Prevents Emergency Readmissions
Undisclosed (general news source) India Overview A new technology offers continuous remote health monitoring for patients at home, particularly those recovering from surgery and the elderly. The system utilizes biosensors to track vital ... -
Pabau Explains AI Patient Monitoring: Multimodal Sensor Fusion Enhances Early Disease Detection and Chronic Disease Management
Pabau UK Overview A Pabau article explains AI patient monitoring, which leverages machine learning to analyze continuous sensor data for early detection of patient condition changes. It highlights multimodal sensor fusion, combining data... -
Brazilian Deeptech Doroth Raises US$4.5 Million to Build Latin America’s First Microfluidic Chip Plant, Targeting 4 Million Annual Production
Latam Republic Brazil Overview Brazilian deeptech company Doroth has raised US$4.51 million to construct Latin America's first microfluidic chip manufacturing facility, aiming for an annual capacity of up to 4 million chips. This strateg... -
Frontiers Reports Sepsis Cytokine Detection Breakthrough: Electrochemical Biosensors Quantify Whole Blood IL-6 in 5 Minutes with 1 pg/mL Sensitivity
Frontiers Switzerland Overview A perspective article in Frontiers highlights the potential of electrochemical biosensors for rapid and precise quantification of cytokine concentrations in sepsis diagnosis and monitoring. Optimized sensor... -
FDA Approves Firmware Update for Dexcom G5 Mobile Continuous Glucose Monitoring System
FDA.gov USA Overview The U.S. FDA has approved minor design changes to the firmware installed on the transmitter component of the Dexcom G5 Mobile Continuous Glucose Monitoring System. Issued as a Premarket Approval (PMA) supplement, thi... -
Achaemenid LLC Receives FDA 510(k) Clearance for iNOS Intraoral Biosensor, Integrating Sleep Apnea Therapy with Continuous SpO2 Monitoring
Sleep Review Magazine USA Overview Achaemenid LLC has obtained FDA 510(k) clearance for its iNOS intraoral biosensor, a prescription device combining an oral appliance with an integrated pulse oximeter. Designed to reduce snoring and mil... -
Wissen Research Forecasts In-Vitro Diagnostics Market to Reach $170.1 Billion by 2031, Driven by 7.7% CAGR
PR Newswire Global Overview This article provides an overview of a market research report published by Wissen Research on the global In-Vitro Diagnostics (IVD) market. The report projects the global IVD market to reach $170.1 billion by ... -
North American Personal Health Intelligence Market Pivots to AI-Powered, Wearable-Driven, Digital Biomarker Ecosystems
Morningstar USA Overview The North American Personal Health Intelligence Platforms market is undergoing a rapid transformation, shifting from basic health tracking to sophisticated, continuously updated, and personalized ecosystems drive... -
Dexcom Secures FDA Authorization for Stelo Glucose Biosensor System, First OTC CGM for Non-Diabetic and Non-Insulin Using Individuals
Devices@FDA (Dexcom) USA Overview Dexcom, Inc. has received FDA authorization for its 'Stelo Glucose Biosensor System,' marking it as the first over-the-counter (OTC) integrated continuous glucose monitor (iCGM) specifically for individu... -
HealthPartners Launches Program Expanding CGM Access and Integrating Pharmacist Support for Insulin-Treated Diabetics
Morningstar (HealthPartners) USA Overview HealthPartners has initiated a new quality improvement program aimed at expanding access to continuous glucose monitoring (CGM) technology and providing personalized support for diabetic patients...
